New Zealand markets open in 4 hours 2 minutes

Edwards Lifesciences Corporation (EW)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
86.96-0.77 (-0.87%)
As of 01:58PM EDT. Market open.

Edwards Lifesciences Corporation

One Edwards Way
Irvine, CA 92614
United States
949 250 2500
https://www.edwards.com

Sector(s)Healthcare
IndustryMedical Devices
Full-time employees19,800

Key executives

NameTitlePayExercisedYear born
Mr. Bernard J. ZovighianCEO & Director2.27MN/A1968
Mr. Scott B. UllemCorporate VP & CFO1.35M6.36M1967
Mr. Donald E. Bobo Jr.Corporate Vice President of Strategy & Corporate Development1.27M2.68M1962
Mr. Larry L. WoodCorporate VP and Group President of TAVR & Surgical Structural Heart1.49M2.13M1966
Mr. Andrew M. DahlPrincipal Accounting Officer, Senior VP & Corporate ControllerN/AN/A1977
Dr. Todd J. Brinton FACC, M.D.Corporate VP of Advanced Technology & Chief Scientific OfficerN/AN/AN/A
Mark WilterdingVice President of Investor RelationsN/AN/AN/A
Mr. Arnold A. PinkstonCorporate VP & General CounselN/AN/A1959
Mr. Dirksen J. LehmanCorporate Vice President of Public AffairsN/AN/AN/A
Ms. Christine Z. McCauleyCorporate Vice President of Human ResourcesN/AN/A1965
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Corporate governance

Edwards Lifesciences Corporation’s ISS governance QualityScore as of 1 July 2024 is 3. The pillar scores are Audit: 5; Board: 4; Shareholder rights: 3; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.